spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: FDA

 HSMN NewsFeed - 16 Jul 2025
Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC(R) Technology
Devices FDA
 HSMN NewsFeed - 10 Jul 2025
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Jul 2025
Neuros Medical Secures $56M Series D to Commercialize the Altius(R) System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Devices Venture Capital
 HSMN NewsFeed - 7 Jul 2025
Boston Scientific Receives FDA Approval for Expanded Labeling of FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 2 Jul 2025
Moon Surgical Receives FDA Clearance for Maestro(TM) Connectivity and Predetermined Change Control Plan for AI-Powered ScoPilot(R)
Devices Surgery FDA
 HSMN NewsFeed - 20 Jun 2025
Lomond Therapeutics Announces U.S. FDA Clearance of IND Application for Lonitoclax, a Selective BCL2 Inhibitor with Limited Immune Suppression and Improved Safety Compared to Venetoclax and Venetoclax- Like Molecules
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Jun 2025
Corvia Medical Closes $55 Million Funding Round to Complete Confirmatory Trial and Pursue FDA Approval of Corvia Atrial Shunt
Devices Cardiology Venture Capital
 HSMN NewsFeed - 13 Jun 2025
U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Jun 2025
TYBR Health Announces FDA 510(k) Clearance for B3 GEL(TM) System, a Flowable Bio-Gel to Protect Healing Tissue and Preserve Function
Devices Regenerative Medicine Surgery FDA
 HSMN NewsFeed - 5 Jun 2025
Penumbra Introduces the Ruby(R) XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Devices Interventional FDA Product Launch
Older FDA stories   Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.